Kenneth W. Imerman

Kenneth Imerman practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Kenneth Imerman's NPI, 1487856431, was assigned on June 1, 2007. Kenneth Imerman graduated from George Washington University School of Medicine in 2005. Kenneth Imerman holds New Mexico license MD2013-0256.

Kenneth Imerman's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Kenneth Imerman's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Kenneth Imerman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kenneth Imerman practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Kenneth Imerman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Kenneth Imerman is licensed in New Mexico.

CMS data shows 165 Medicare services from Kenneth Imerman across 7 procedure codes in 2024, for 139 Medicare patients. Medicare paid $19,068 for them.

CMS counts 139 Medicare patients who saw Kenneth Imerman in 2026. The largest group is 65 to 74, with 46 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kenneth Imerman's median patient age at 60, with 52% women.

In 2026, Kenneth Imerman wrote 1,324 Medicare Part D claims for 102 patients. 84% of them were for generic drugs. CMS names the drug for 1,188 of them, across 27 drugs with 11 or more claims each, at $198,680 in total drug cost. In 2023, CMS named 1,284 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Kenneth Imerman for performance year 2026, reported as part of a group. Kenneth Imerman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kenneth Imerman as offering telehealth.

CMS Open Payments shows 45 general payments to Kenneth Imerman from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. LivaNova PLC paid the most, $932.

Kenneth Imerman graduated from George Washington University School of Medicine in 2005.